Table 1.
Details of Included Studies.
Study | Study Design | Country | Treatment | Dosage | Sample Size | Scheme | Treatment Cycle | Inclusion Criteria | Sample Size Calculations |
---|---|---|---|---|---|---|---|---|---|
Mohammad RS (2006) | RCT | Iran | Tramadol; Placebo | 50 mg | 32; 32 | 2 hr before sexual activity | 8 weeks | Potent married men aged 20–52 years who had an IELT of less than 2 min that occurred in more than 90% of coitus. | No |
Emad AS (2008) | Single blind crossover study | USA | Tramadol; Placebo | 25 mg | 30; 30 | 1–2 hr before sexual activity | 8 weeks | Patients were IELT <2 min in 80% of intercourse attempts, with at least one intercourse episode per week. | No |
Moheiddin A (2010) | RCT | Egypt | Tramadol; Paroxetine | 50 mg; 20 mg | 17; 18 | 2–3 hr before sexual activity | 6 weeks | Only cases with lifelong PE were included. PE was defined according to the definition of DSM-IV-RT. | No |
David BO (2011) | RCT | USA | Tramadol; Tramadol; Placebo | 62 mg; 89 mg | 206; 198; 200 | 2–8 hr before sexual activity | 12 weeks | The population baseline median IELT was <60 s in each treatment arm. | No |
XIONG GG (2011) | RCT | China | Tramadol; Placebo | 50 mg | 36; 36 | 2 hr before intercourse | 8 weeks | Potent married men who had an IELT of <2 min over a 3-month period had been in a stable relationship with uncontrolled ejaculation. | No |
Eid MA (2011) | Single blind base study | Egypt | Tramadol; Paroxetine; Placebo | 50 mg; 20 mg | 50; 50; 50 | 3–4 hr before sexual activity | 3 weeks | Patients with IELT of less than 2 min in 80% of intercourses for 3 weeks for at least 10 successive intercourses. | No |
Mehmet K (2012) | Single blind crossover study | Turkey | Tramadol; Placebo | 25 mg | 30; 30 | 2 hr before intercourse | 8 weeks | All participants had primary PE and stable relationship with a partner for 6 months and possible sexual attempts of once a week or more. | No |
Amil HK (2013) | RCT | India | Tramadol; Placebo | 100 mg | 30; 30 | Daily for 4 weeks and then 2 or 8 hr before intercourse for 4 weeks | 8 weeks | Patients with IELT of less than 1 min with minimal sexual stimulation before or after ejaculation. | No |
Bayoumy IE (2013) | RCT | Egypt | Tramadol; Tramadol; Tramadol; | 25 mg; 50 mg; 100 mg | 100; 100; 100 | 2–3 hr before intercourse | 24weeks | Men aged 25–50 years with a stable monogamous heterosexual relationship with regular sexual intercourse at least twice per week with a cooperative female partner. | No |
Tarek AG (2013) | RCT | Egypt | Tramadol; Paroxetine; Placebo | 50 mg; 20 mg | 30; 30; 30 | 2 hr before intercourse; 4 hr before intercourse | 4 weeks | Patients included were those with PE for >1 year and who had an IELT of <2 min in >75% of episodes of vaginal sexual intercourse over a 2-week period. | Yes |
Adel K (2015) | RCT | Egypt | Tramadol; Tramadol; Placebo | 50 mg; 100 mg | 60; 60; 60 | 2–3 hr before intercourse | 8 weeks | Participants were potent with no history of erectile dysfunction, and had a stable, regular (≥1 sexual attempts per week), single‑partner heterosexual relationship for ≥1 year. | Yes |
Seyyed HS (2015) | RCT | Iran | Tramadol; Placebo | 100 mg | 20; 20 | 2 hr before intercourse | 3 weeks | Men who had an IELT of <1 min had a stable relationship with uncontrolled ejaculation. | Yes |
Ali HM (2018) | RCT | Iran | Tramadol; Paroxetine; Placebo | 50 mg; 20 mg | 50; 50; 50 | 2–3 hr before intercourse | 12 weeks | Men were between 18 to 55 years old, married, and had a stable relationship for at least 6 months with uncontrolled ejaculation that occurred before or within 1 min of vaginal intercourse. | No |
Muhammad FUR (2020) | RCT | PAK | Tramadol; Paroxetine | 50 mg; 20 mg | 53; 53 | 2 hr before intercourse; 4 hr before intercourse | 8 weeks | Potent married men aged 30 to 40 years who had been in a relationship for at least 6 months with uncontrolled ejaculation within 1 min of vaginal intromission. | Yes |
Note. RCT = randomized controlled trial; PE = premature ejaculation; IELT = intravaginal ejaculatory latency time; DSM-IV-TR = Diagnostic and Statistical Manual, Fourth Edition, Text Revision.